Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$7.03 - $16.51 $1,757 - $4,127
-250 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$5.76 - $11.95 $2,016 - $4,182
-350 Reduced 58.33%
250 $2,000
Q3 2020

Nov 16, 2020

BUY
$6.17 - $18.82 $308 - $941
50 Added 9.09%
600 $7,000
Q2 2020

Aug 12, 2020

BUY
$1.73 - $6.76 $951 - $3,718
550 New
550 $3,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Global Wealth Management Investment Advisory, Inc. Portfolio

Follow Global Wealth Management Investment Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Management Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Management Investment Advisory, Inc. with notifications on news.